CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE

美国国立卫生研究院(NIH)、尤尼斯·肯尼迪·施莱弗国家儿童健康研究所和 人类发展(NICHD)，是进行基础、临床研究的主要联邦机构 研究开发新的避孕药具并评估现有的避孕方法 和生殖健康。NICHD内的人口研究中心成立于#年 1968年由卫生、教育和福利部部长提出，其重要目标是开发新的 通过使用合同和赠款采取避孕措施。在CPR中，避孕和生殖 卫生处(CRHB)长期以来一直支持几个临床前避孕测试设施以及 合成化学品和合成肽配方的设施。 为了进一步扩大他们的避孕开发能力，CRHB于1996年成立了NICHD 避孕临床试验网络(CCTN)目前的中央电视台已经进行了一期、二期和三期 女性和男性避孕方法的临床试验。 随着CCTN的重新竞争，临床站点将进行I、II、III和IV期临床 对多种新的或现有的女性避孕方法进行试验。

The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is the lead Federal agency for the conduct of basic, clinical research to develop new contraceptives and to evaluate existing methods of contraception and reproductive health. The Center for Population Research (CPR), within NICHD, was established in 1968 by the Secretary of Health Education and Welfare, with the important goal of developing new contraceptives through the use of contracts and grants. Within CPR, the Contraception and Reproductive Health Branch (CRHB) has long supported several preclinical contraceptive testing facilities as well as facilities for synthetic chemical and synthetic peptide formulation. To further expand their contraceptive development capabilities, in 1996 CRHB established the NICHD Contraceptive Clinical Trials Network (CCTN). The current CCTN has conducted Phase I, II, and III clinical trials of both female and male contraceptive methods. With the recompetition of the CCTN, clinical sites will perform Phase I, II, III, and Phase IV clinical trials of a wide variety of new or existing female contraceptive methods.